Skip to content

VYNE — Vyne Therapeutics Inc Institutional Holders · Q2 2026

Who owns Vyne Therapeutics Inc (VYNE)? 49 institutions reported holding $9.44M in SEC 13F filings for Q2 2026 (period ended 2026-06-30). Largest holders: ADAR1 Capital Management, LLC ($1.9M), Nantahala Capital Management, LLC ($1.3M), Lynx1 Capital Management LP ($1.1M).

RankInstitutionValueSharesChange
1ADAR1 Capital Management, LLC$1.9M3.0MAdded
2Nantahala Capital Management, LLC$1.3M2.0MHold
3Lynx1 Capital Management LP$1.1M1.6MHold
4Shay Capital LLC$947,8431.5MTrimmed
5Deeter Investments LLP$650,7001.0MHold
6T3 Companies, LLC$614,912945,000Hold
7BRAIDWELL LP$596,091916,077Hold
8KVP Capital Advisors, LP$325,709500,551Hold
9CITADEL ADVISORS LLC$304,825468,457Trimmed
10VANGUARD GROUP INC$291,648448,000Trimmed
11TWO SIGMA INVESTMENTS, LP$285,539438,818Added
12ACADIAN ASSET MANAGEMENT LLC$248,000381,797Hold
13Ikarian Capital, LLC$172,379264,912Hold
14GEODE CAPITAL MANAGEMENT, LLC$168,017258,203Trimmed
15SUSQUEHANNA INTERNATIONAL GROUP, LLP$77,405118,957Added
16Rangeley Capital, LLC$73,571113,064Trimmed
17XTX Topco Ltd$51,22478,721Trimmed
18GSA CAPITAL PARTNERS LLP$47,00071,533New
19SUPERSTRING CAPITAL MANAGEMENT LP$39,86861,269New
20UBS Group AG$38,14758,597Trimmed
21STALEY CAPITAL ADVISERS INC$33,49351,472Hold
22BlackRock, Inc.$28,89544,405Hold
23NORTHERN TRUST CORP$28,42143,677Added
24JANE STREET GROUP, LLC$26,66240,974Trimmed
25TWO SIGMA SECURITIES, LLC$26,48240,697New

Source: SEC Form 13F filings · as of 2026-06-30